EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.14.14.19 | additional information | complete 17-hydroxylase deficiency, 17HD, does not play a role in C19 steroid metabolism, but cortisol-treated 17HD patients cannot produce androstenedione, phenotype, overview | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.32 | 17alpha-Hydroxypregnenolone | Homo sapiens | 17,20-lyase activity | Dehydroepiandrosterone + acetaldehyde | - |
? | |
1.14.14.32 | 17alpha-hydroxyprogesterone + [reduced NADPH-hemoprotein reductase] + O2 | Homo sapiens | 17,20-lyase activity | androstenedione + acetate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.14.14.19 | Homo sapiens | - |
- |
- |
1.14.14.32 | Homo sapiens | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.14.14.19 | additional information | CYP17 does not perform side-chain cleavage of cortisol and its metabolites, e.g. 11-oxo-etiocholanolone and 11beta-hydroxyetiocholanolone | Homo sapiens | ? | - |
? | |
1.14.14.32 | 17alpha-Hydroxypregnenolone | 17,20-lyase activity | Homo sapiens | Dehydroepiandrosterone + acetaldehyde | - |
? | |
1.14.14.32 | 17alpha-hydroxyprogesterone + [reduced NADPH-hemoprotein reductase] + O2 | 17,20-lyase activity | Homo sapiens | androstenedione + acetate + [oxidized NADPH-hemoprotein reductase] + H2O | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.14.14.19 | 17-hydroxylase/C17,20-lyase | - |
Homo sapiens |
1.14.14.19 | CYP17 | - |
Homo sapiens |
1.14.14.32 | 17-hydroxylase/C17,20-lyase | - |
Homo sapiens |
1.14.14.32 | CYP17 | - |
Homo sapiens |